76.2%
OSU cohort3radioimmunotherapiescancerchimeric antigen receptor (CAR)-T cell therapies
…y donors (Providence cohort) and cancer patients (SIIREN study, OSU cohort3) who had received the SARS-CoV-2 S-protein mRNA vaccine. Single…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: OSU cohort3 ×
OSU cohort3
This institution is selected. Its supporting articles are shown below.